Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Injury | 5 | 2011 | 64 | 0.710 |
Why?
|
Neutrophil Infiltration | 1 | 2011 | 9 | 0.410 |
Why?
|
Thoracic Injuries | 2 | 2009 | 50 | 0.370 |
Why?
|
Lung | 1 | 2011 | 233 | 0.350 |
Why?
|
Wounds, Nonpenetrating | 4 | 2011 | 90 | 0.310 |
Why?
|
Thoracotomy | 1 | 2007 | 22 | 0.300 |
Why?
|
Contusions | 3 | 2010 | 41 | 0.250 |
Why?
|
Wounds and Injuries | 4 | 2011 | 250 | 0.230 |
Why?
|
Pneumonia, Bacterial | 2 | 2011 | 31 | 0.170 |
Why?
|
Cross Infection | 2 | 2011 | 46 | 0.170 |
Why?
|
Finite Element Analysis | 2 | 2010 | 80 | 0.170 |
Why?
|
Hospital Mortality | 2 | 2011 | 186 | 0.160 |
Why?
|
Respiratory Distress Syndrome, Adult | 2 | 2008 | 55 | 0.160 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2008 | 40 | 0.150 |
Why?
|
Models, Biological | 2 | 2010 | 373 | 0.150 |
Why?
|
Intensive Care Units | 2 | 2010 | 118 | 0.110 |
Why?
|
Receptors, Interleukin-8B | 1 | 2011 | 4 | 0.100 |
Why?
|
Chemokines, CXC | 1 | 2011 | 9 | 0.100 |
Why?
|
Chemokine CXCL2 | 1 | 2011 | 9 | 0.100 |
Why?
|
Chemokine CXCL1 | 1 | 2011 | 16 | 0.100 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2011 | 41 | 0.100 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2011 | 15 | 0.100 |
Why?
|
Emergency Treatment | 1 | 2011 | 42 | 0.100 |
Why?
|
Bacteria | 1 | 2011 | 45 | 0.100 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 97 | 0.100 |
Why?
|
Early Ambulation | 1 | 2010 | 7 | 0.100 |
Why?
|
Surgical Procedures, Operative | 1 | 2011 | 74 | 0.100 |
Why?
|
Medical Order Entry Systems | 1 | 2010 | 13 | 0.090 |
Why?
|
Acute Lung Injury | 1 | 2010 | 30 | 0.090 |
Why?
|
Length of Stay | 1 | 2011 | 292 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2010 | 871 | 0.090 |
Why?
|
Accidents, Traffic | 2 | 2009 | 190 | 0.090 |
Why?
|
Weight-Bearing | 1 | 2009 | 40 | 0.090 |
Why?
|
Injury Severity Score | 4 | 2011 | 115 | 0.080 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 285 | 0.080 |
Why?
|
Cohort Studies | 5 | 2010 | 1688 | 0.080 |
Why?
|
Pulmonary Alveoli | 1 | 2007 | 19 | 0.080 |
Why?
|
Interleukin-10 | 1 | 2007 | 30 | 0.080 |
Why?
|
Emergency Service, Hospital | 1 | 2011 | 430 | 0.080 |
Why?
|
Pericardial Window Techniques | 1 | 2007 | 1 | 0.080 |
Why?
|
Subclavian Artery | 1 | 2007 | 6 | 0.080 |
Why?
|
Heart Injuries | 1 | 2007 | 8 | 0.070 |
Why?
|
Neutrophils | 1 | 2007 | 102 | 0.070 |
Why?
|
Bronchi | 1 | 2007 | 41 | 0.070 |
Why?
|
Esophagus | 1 | 2007 | 22 | 0.070 |
Why?
|
Male | 11 | 2011 | 17815 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2007 | 49 | 0.070 |
Why?
|
Trachea | 1 | 2007 | 55 | 0.070 |
Why?
|
Pattern Recognition, Automated | 1 | 2007 | 34 | 0.070 |
Why?
|
Spleen | 1 | 2007 | 82 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2007 | 72 | 0.070 |
Why?
|
Humans | 11 | 2011 | 29123 | 0.070 |
Why?
|
Insulin | 1 | 2007 | 346 | 0.070 |
Why?
|
Mice | 1 | 2011 | 2370 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2007 | 157 | 0.060 |
Why?
|
Adult | 7 | 2011 | 8426 | 0.060 |
Why?
|
Critical Care | 3 | 2011 | 114 | 0.060 |
Why?
|
Animals | 3 | 2011 | 7299 | 0.060 |
Why?
|
Female | 9 | 2011 | 18173 | 0.060 |
Why?
|
Algorithms | 1 | 2007 | 462 | 0.060 |
Why?
|
Middle Aged | 7 | 2011 | 10834 | 0.060 |
Why?
|
Aged | 5 | 2011 | 9492 | 0.050 |
Why?
|
Adolescent | 4 | 2009 | 3255 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2007 | 67 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 787 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2010 | 747 | 0.040 |
Why?
|
Prospective Studies | 2 | 2010 | 2021 | 0.030 |
Why?
|
Rats | 2 | 2010 | 1604 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2010 | 2109 | 0.030 |
Why?
|
Risk Assessment | 2 | 2008 | 1306 | 0.030 |
Why?
|
Young Adult | 2 | 2009 | 2402 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2011 | 3101 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2011 | 3112 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 129 | 0.020 |
Why?
|
Resuscitation | 1 | 2011 | 56 | 0.020 |
Why?
|
Elasticity | 1 | 2010 | 34 | 0.020 |
Why?
|
Regression Analysis | 1 | 2011 | 274 | 0.020 |
Why?
|
Computers | 1 | 2010 | 17 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 293 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 61 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 85 | 0.020 |
Why?
|
Cause of Death | 1 | 2011 | 220 | 0.020 |
Why?
|
Databases, Factual | 1 | 2011 | 332 | 0.020 |
Why?
|
Computer Simulation | 1 | 2010 | 207 | 0.020 |
Why?
|
Thoracic Wall | 1 | 2009 | 6 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2010 | 118 | 0.020 |
Why?
|
Compressive Strength | 1 | 2009 | 20 | 0.020 |
Why?
|
Manikins | 1 | 2009 | 33 | 0.020 |
Why?
|
Acceleration | 1 | 2009 | 60 | 0.020 |
Why?
|
Abbreviated Injury Scale | 1 | 2009 | 57 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 2008 | 14 | 0.020 |
Why?
|
Automation | 1 | 2008 | 30 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2008 | 111 | 0.020 |
Why?
|
Disease Progression | 1 | 2010 | 572 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2010 | 726 | 0.020 |
Why?
|
Age Factors | 1 | 2011 | 1108 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2007 | 23 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2007 | 90 | 0.020 |
Why?
|
Probability | 1 | 2007 | 150 | 0.020 |
Why?
|
Reference Values | 1 | 2007 | 224 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 532 | 0.020 |
Why?
|
North Carolina | 1 | 2011 | 1423 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2011 | 670 | 0.020 |
Why?
|
Survival Analysis | 1 | 2007 | 440 | 0.020 |
Why?
|
Time Factors | 1 | 2011 | 2001 | 0.020 |
Why?
|
Apoptosis | 1 | 2007 | 337 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 641 | 0.020 |
Why?
|
Blood Glucose | 1 | 2007 | 466 | 0.020 |
Why?
|
United States | 1 | 2011 | 3632 | 0.010 |
Why?
|
Risk Factors | 1 | 2010 | 3537 | 0.010 |
Why?
|